BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 17450132)

  • 1. pVHL and GSK3beta are components of a primary cilium-maintenance signalling network.
    Thoma CR; Frew IJ; Hoerner CR; Montani M; Moch H; Krek W
    Nat Cell Biol; 2007 May; 9(5):588-95. PubMed ID: 17450132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The VHL tumor suppressor: riding tandem with GSK3beta in primary cilium maintenance.
    Thoma CR; Frew IJ; Krek W
    Cell Cycle; 2007 Aug; 6(15):1809-13. PubMed ID: 17671433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. pVHL and PTEN tumour suppressor proteins cooperatively suppress kidney cyst formation.
    Frew IJ; Thoma CR; Georgiev S; Minola A; Hitz M; Montani M; Moch H; Krek W
    EMBO J; 2008 Jun; 27(12):1747-57. PubMed ID: 18497742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VHL-gene deletion in single renal tubular epithelial cells and renal tubular cysts: further evidence for a cyst-dependent progression pathway of clear cell renal carcinoma in von Hippel-Lindau disease.
    Montani M; Heinimann K; von Teichman A; Rudolph T; Perren A; Moch H
    Am J Surg Pathol; 2010 Jun; 34(6):806-15. PubMed ID: 20431476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formation of primary cilia in the renal epithelium is regulated by the von Hippel-Lindau tumor suppressor protein.
    Esteban MA; Harten SK; Tran MG; Maxwell PH
    J Am Soc Nephrol; 2006 Jul; 17(7):1801-6. PubMed ID: 16775032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal cyst development in mice with conditional inactivation of the von Hippel-Lindau tumor suppressor.
    Rankin EB; Tomaszewski JE; Haase VH
    Cancer Res; 2006 Mar; 66(5):2576-83. PubMed ID: 16510575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined deletion of Vhl, Trp53 and Kif3a causes cystic and neoplastic renal lesions.
    Guinot A; Lehmann H; Wild PJ; Frew IJ
    J Pathol; 2016 Jul; 239(3):365-73. PubMed ID: 27126173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined mutation of Vhl and Trp53 causes renal cysts and tumours in mice.
    Albers J; Rajski M; Schönenberger D; Harlander S; Schraml P; von Teichman A; Georgiev S; Wild PJ; Moch H; Krek W; Frew IJ
    EMBO Mol Med; 2013 Jun; 5(6):949-64. PubMed ID: 23606570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of cyclin D1 and other novel targets for the von Hippel-Lindau tumor suppressor gene by expression array analysis and investigation of cyclin D1 genotype as a modifier in von Hippel-Lindau disease.
    Zatyka M; da Silva NF; Clifford SC; Morris MR; Wiesener MS; Eckardt KU; Houlston RS; Richards FM; Latif F; Maher ER
    Cancer Res; 2002 Jul; 62(13):3803-11. PubMed ID: 12097293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Priming-dependent phosphorylation and regulation of the tumor suppressor pVHL by glycogen synthase kinase 3.
    Hergovich A; Lisztwan J; Thoma CR; Wirbelauer C; Barry RE; Krek W
    Mol Cell Biol; 2006 Aug; 26(15):5784-96. PubMed ID: 16847331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic deletion of the long isoform of the von Hippel-Lindau tumour suppressor gene product alters microtubule dynamics.
    Frew IJ; Smole Z; Thoma CR; Krek W
    Eur J Cancer; 2013 Jul; 49(10):2433-40. PubMed ID: 23541568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Von Hippel-Lindau syndrome: molecular mechanisms of the disease.
    Calzada MJ
    Clin Transl Oncol; 2010 Mar; 12(3):160-5. PubMed ID: 20231120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The von hippel-lindau tumor suppressor protein: an update.
    Kaelin WG
    Methods Enzymol; 2007; 435():371-83. PubMed ID: 17998064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. VHL inactivation induces HEF1 and Aurora kinase A.
    Xu J; Li H; Wang B; Xu Y; Yang J; Zhang X; Harten SK; Shukla D; Maxwell PH; Pei D; Esteban MA
    J Am Soc Nephrol; 2010 Dec; 21(12):2041-6. PubMed ID: 20864688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary cilium formation requires von hippel-lindau gene function in renal-derived cells.
    Lutz MS; Burk RD
    Cancer Res; 2006 Jul; 66(14):6903-7. PubMed ID: 16849532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Von hippel-lindau: a tumor suppressor links microtubules to ciliogenesis and cancer development.
    Kuehn EW; Walz G; Benzing T
    Cancer Res; 2007 May; 67(10):4537-40. PubMed ID: 17510376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The von Hippel-Lindau tumor suppressor gene and kidney cancer.
    Kaelin WG
    Clin Cancer Res; 2004 Sep; 10(18 Pt 2):6290S-5S. PubMed ID: 15448019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined Deletion of Vhl and Kif3a Accelerates Renal Cyst Formation.
    Lehmann H; Vicari D; Wild PJ; Frew IJ
    J Am Soc Nephrol; 2015 Nov; 26(11):2778-88. PubMed ID: 25788526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Von Hippel-Lindau disease.
    Kaelin WG
    Annu Rev Pathol; 2007; 2():145-73. PubMed ID: 18039096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nek1 phosphorylates Von Hippel-Lindau tumor suppressor to promote its proteasomal degradation and ciliary destabilization.
    Patil M; Pabla N; Huang S; Dong Z
    Cell Cycle; 2013 Jan; 12(1):166-71. PubMed ID: 23255108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.